A detailed history of Burleson & Company, LLC transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Burleson & Company, LLC holds 47 shares of IQV stock, worth $9,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares
47
Previous 47 -0.0%
Holding current value
$9,450
Previous $9,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

SELL
$196.45 - $252.29 $589 - $756
-3 Reduced 6.0%
47 $10,000
Q1 2022

Apr 25, 2022

BUY
$210.56 - $273.58 $631 - $820
3 Added 6.38%
50 $12,000
Q4 2021

Jan 25, 2022

SELL
$238.37 - $282.61 $33,610 - $39,848
-141 Reduced 75.0%
47 $13,000
Q1 2021

May 12, 2021

BUY
$173.0 - $194.59 $32,524 - $36,582
188 New
188 $36,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $37.3B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Burleson & Company, LLC Portfolio

Follow Burleson & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burleson & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burleson & Company, LLC with notifications on news.